Oral Therapies

This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.

Related Keywords

United States ,Paris ,France General ,France ,American ,J Clin Dermatol ,Mona Shahriari ,National Psoriasis Foundation ,American Academy Of Dermatology ,Program For Evaluation ,Psoriasis Activity Severity Index ,American Academy ,Dermatology National Psoriasis Foundation ,Safety Trial Evaluating ,